|
|
| 17.88 Data as of Apr 17 |  +0.13 / +0.73%Today’s Change | 16.49 Today|||52-Week Range 28.42 | -26.36% Year-to-Date |
| Broadfin Capital Initiates New Positions In Corium International Inc (CORI), AMAG Pha... Apr 17 / Investing Channel |
| Previous close | 17.75 |
| Today’s open | 17.67 |
| Day’s range | 17.33 - 18.13 |
| Volume | 324,142 |
| Average volume (3 months) | 546,603 |
| Market cap | $388.5M |
| Dividend yield | -- |
| Earnings growth (last year) | +43.59% |
| Earnings growth (this year) | +57.95% |
| Earnings growth (next 5 years) | +35.00% |
| Revenue growth (last year) | -5.30% |
| P/E ratio | NM |
| Price/Sales | 6.52 |
| Price/Book | 2.25 |
| Today’s change | Today’s % change | |
|---|---|---|
| BDSIBioDelivery Sciences... | +0.02 | +0.27% |
| DNDNDendreon Corp | -0.04 | -1.49% |
| OXFDOxford Immunotec Glo... | +0.11 | +0.62% |
| GERNGeron Corp | -0.03 | -1.52% |
| Next reporting date | April 29, 2014 |
| EPS forecast (this quarter) | -$0.10 |
| Annual revenue (last year) | $80.9M |
| Annual profit (last year) | -$9.6M |
| Net profit margin | -11.88% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director William K. Heiden |
Chief Operating Officer & Executive Vice President Frank E. Thomas |
Corporate headquarters Lexington, Massachusetts |
.
